DCGI grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’

New Delhi: Drugs Controller General of India grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’.

The Pune-based company earlier stated that ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.

After Prime Minister Narendra Modi visited the company’s pandemic level facility in Pune last month, SII Chief Executive Officer (CEO) Adar Poonawalla had said that indications suggest that the Central government may purchase 300-400 million doses by July 2021.

The post DCGI grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’ appeared first on NewsroomPost.



from NewsroomPost https://ift.tt/388HijW
https://ift.tt/38c2XYF

Comments